Why the study?
Does lovastatin or gemfibrozil improve lipid and lipoprotein levels in normolipidemic patients with reduced HDL cholesterol?
Does lovastatin or gemfibrozil improve lipid and lipoprotein levels in normolipidemic patients with reduced HDL cholesterol?
In normolipidemic patients with low HDL cholesterol, lovastatin produces a better overall change in lipoprotein cholesterol and apolipoprotein B levels compared to gemfibrozil, although neither drug markedly raises HDL levels.
No takes yet. Share an insight, caveat, or question.
Lovastatin offers superior atherogenic lipid reduction versus gemfibrozil in normolipidemic low-HDL patients; extends statin utility beyond hypercholesterolemia.
Gloria Lena Vega (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: